Point72 Asset Management, L.P. 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:56 pm Sale |
2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 888,870 2.000% |
-760,870 (-46.12%) |
Filing |
| 2024-02-14 4:20 pm Purchase |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 1,649,740 6.400% |
499,092 (+43.37%) |
Filing |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 1,150,648 7.400% |
189,778 (+19.75%) |
Filing |
| 2022-11-09 9:10 pm Purchase |
2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 960,870 9.990% |
960,870 (New Position) |
Filing |